New Delhi, Dec 5 (PTI) A US Court has dismissed a lawsuit filed by HDT Bio Corp against Pune-based Emcure Pharmaceuticals.

A Federal court in Seattle, Washington, has dismissed the lawsuit lawsuit filed by HDT against Gennova Biopharmaceuticals, a unit of Emcure, regarding Covid-19 vaccine technology.

Also Read | CAT 2023 Exam: Response Sheet of Common Admission Test Examination Released at iimcat.ac.in, Raise Objections Till December 8.

HDT had named Emcure as a party in the suit, alleging non-payment of royalties and demanded a compensation of at least USD 950 million.

When contacted a company spokesperson said, "The ruling vindicates our stand".

Also Read | Bade Miyan Chote Miyan: Teaser of Akshay Kumar and Tiger Shroff Starrer To Release on Republic Day, 2024.

Emcure had contended in the court that the lawsuit was illegitimate and brought by HDT to compensate for its business shortcomings.

HDT Bio had alleged that the Pune-based firm had stolen its vaccine technology which it had licensed to Gennova for manufacture and distribution in India.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)